Search

Your search keyword '"Courvoisier, Delphine"' showing total 1,199 results

Search Constraints

Start Over You searched for: Author "Courvoisier, Delphine" Remove constraint Author: "Courvoisier, Delphine"
1,199 results on '"Courvoisier, Delphine"'

Search Results

202. Serology-informed estimates of SARS-CoV-2 infection fatality risk in Geneva, Switzerland

203. Experiences with a new biplanar low-dose X-ray device for imaging the facial skeleton: A feasibility study

204. Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritis

205. Additional file 1 of Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritis

206. Measuring ACPA in the general population or primary care: is it useful?

207. Identification of highly active systemic lupus erythematosus by combined type I interferon and neutrophil gene scores vs classical serologic markers

208. Do welfare regimes moderate cumulative dis/advantages over the life course? : cross-national evidence from longitudinal SHARE data

209. Big Five Personality Traits and Disabling Chronic Low Back Pain: Association with Fear-Avoidance, Anxious and Depressive Moods

215. Significance of eosinophilia in granulomatosis with polyangiitis: data from the French Vasculitis Study Group Registry.

216. Risk of Reinfection After Seroconversion to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Population-based Propensity-score Matched Cohort Study.

217. Occupational risk of SARS-CoV-2 infection and reinfection during the second pandemic surge: a cohort study.

220. The impact of seropositivity on the effectiveness of biologic anti-rheumatic agents: results from a collaboration of 16 registries

222. Cover Image: Volume 35 Issue 7

227. Do Welfare Regimes Moderate Cumulative Dis/advantages Over the Life Course? Cross-National Evidence from Longitudinal SHARE Data

229. Comparative effectiveness of TNF inhibitors and tocilizumab with and without conventional synthetic disease-modifying antirheumatic drugs in a pan-European observational cohort of bio-naïve patients with rheumatoid arthritis

230. Echocardiographic features in antiphospholipid-negative Sneddon’s syndrome and potential association with severity of neurological symptoms or recurrence of strokes: a longitudinal cohort study

233. International Consortium for Health Outcome Measurement Set of Outcomes That Matter to People Living With Inflammatory Arthritis: Consensus From an International Working Group

240. Heterogeneity in the Pattern of Use of JAK-inhibitors Between Countries Participating in an International Collaboration of Registers of Rheumatoid Arthritis Patients (the JAK-pot Study)

241. Impact of legal status change on undocumented migrants’ health and well-being (Parchemins): protocol of a 4-year, prospective, mixed-methods study

242. Response to Commentary

244. Age-related decline of cognitive resources precedes and explains the decline in physical activity

245. Physical activity cancels the negative impact of adverse childhood experiences and depression on functional dependence

246. Incidence of healthcare-associated coronavirus disease 2019 (COVID-19) in the state of Geneva

247. International Consortium for Health Outcome Measurement Set of Outcomes That Matter to People Living With Inflammatory Arthritis : Consensus From an International Working Group

248. Imputing missing data of function and disease activity in rheumatoid arthritis registers:What is the best technique?

249. Validation of the clinical frailty score (CFS) in French language

250. Life-course circumstances and frailty in old age within different European welfare regimes : a longitudinal study with SHARE

Catalog

Books, media, physical & digital resources